ARKG

ARK Genomic Revolution Multi-Sector ETF

Up$34.34
+$0.52
(+1.54%)
As of 8:00:00 PM EDT | 7/22/19  |  Market Closed

ARKG Trading Data

Open

$33.92

Low Price

$33.92

High Price

$34.44

Previous Last Price

$33.82

Bid Size

$0 X 0

Ask Size

$0 X 0

ARKG Portfolio Data

AUM

$458,430,100

Shares

13,555

PE Ratio

28.06

Price / Book Ratio

4.48

Expense Ratio

0.75

Net Asset Value

$33.82

Volume

Volume

89,700

Avg. Volume (YDT)

146,223

Dollar Volume

$2,737,485

Weekly Avg. Volume

105,260

Monthly Avg. Volume

156,045

Quarterly Avg. Volume

145,933

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Holdings

Top 10 Holdings

INVITAE CORP (NVTA)
10.11%
ILLUMINA INC (ILMN)
9.41%
INTELLIA THERAPEUTICS INC (NTLA)
7.16%
CRISPR THERAPEUTICS AG (CRSP)
6.75%
EDITAS MEDICINE INC (EDIT)
5.77%
VERACYTE INC (VCYT)
4.72%
TELADOC HEALTH INC (TDOC)
4.36%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.31%
NANOSTRING TECHNOLOGIES INC (NSTG)
4.22%
CELLECTIS - ADR (CLLS)
3.07%

Total ARKG Holdings

Total Holdings: 34

INVITAE CORP (NVTA)
10.11%
ILLUMINA INC (ILMN)
9.41%
INTELLIA THERAPEUTICS INC (NTLA)
7.16%
CRISPR THERAPEUTICS AG (CRSP)
6.75%
EDITAS MEDICINE INC (EDIT)
5.77%
VERACYTE INC (VCYT)
4.72%
TELADOC HEALTH INC (TDOC)
4.36%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.31%
NANOSTRING TECHNOLOGIES INC (NSTG)
4.22%
CELLECTIS - ADR (CLLS)
3.07%
BRISTOL-MYERS SQUIBB CO (BMY)
3%
IONIS PHARMACEUTICALS INC (IONS)
2.79%
INOVIO PHARMACEUTICALS INC (INO)
2.51%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
2.48%
INCYTE CORP (INCY)
2.39%
COMPUGEN LTD (CGEN)
2.26%
NVIDIA CORP (NVDA)
2.07%
REGENERON PHARMACEUTICALS (REGN)
1.94%
RUBIUS THERAPEUTICS INC (RUBY)
1.86%
CERUS CORP (CERS)
1.82%
CODEXIS INC (CDXS)
1.69%
GUARDANT HEALTH INC (GH)
1.58%
SYROS PHARMACEUTICALS INC (SYRS)
1.48%
PERSONALIS INC (PSNL)
1.48%
TWIST BIOSCIENCE CORP (TWST)
1.47%
FATE THERAPEUTICS INC (FATE)
1.41%
BLUEBIRD BIO INC (BLUE)
1.4%
SERES THERAPEUTICS INC (MCRB)
1.25%
APPLE INC (AAPL)
1.09%
CELLULAR BIOMEDICINE GROUP I (CBMG)
1.03%
CAREDX INC (CDNA)
0.92%
PLURISTEM THERAPEUTICS INC (PSTI)
0.71%
ORGANOVO HOLDINGS INC (ONVO)
0.54%
ARK Genomic Revolution Multi-Sector ETF (ARKG)
0%

ARKG Technicals

Alpha

5.34

Beta

1.87

Leverage

Long

Standard Deviation

2.43

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.8

ARKG Performance

YTD Return

43.2%

1 Year Return

9.92%

3 Year Return

83.34%

5 Year Return

0%

10 Year Return

70.85%

ARKG Related Articles